EntryPoint Capital’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,469
Closed -$307K 892
2026
Q1
$307K Hold
3,469
0.09% 455
2025
Q4
$272K Sell
3,469
-776
-18% -$59K 0.11% 404
2025
Q3
$284K Buy
+4,245
New +$306K 0.11% 388
2024
Q2
Sell
-741
Closed -$81.3K 1679
2024
Q1
$81.3K Buy
741
+193
+35% +$19.4K 0.07% 527
2023
Q4
$57.4K Buy
+548
New +$53.4K 0.06% 650

Other funds holding MLAB

EntryPoint Capital's MLAB Position: Q2 2026 in Review

EntryPoint Capital sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 3,469 shares — an estimated $307K sold.

EntryPoint Capital first reported a position in MLAB in Q4 2023 and held it in 5 quarters. The position peaked at $307K in Q1 2026. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • EntryPoint Capital reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
  • EntryPoint Capital sold 3,469 Mesa Laboratories shares in Q2 2026, an estimated $307K.
  • EntryPoint Capital first reported a position in Mesa Laboratories in Q4 2023 and held it in 5 quarters.
  • EntryPoint Capital's Mesa Laboratories position peaked at $307K in Q1 2026.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.